Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis
Sign Up to like & getrecommendations! Published in 2021 at "Drugs"
DOI: 10.1007/s40265-021-01650-7
Abstract: Ofatumumab (Kesimpta ® ) is a fully human anti-CD20 monoclonal antibody that can be self-administered by patients and is approved in several countries worldwide for the treatment of relapsing forms of multiple sclerosis (MS). In… read more here.
Keywords: generally manageable; relapsing forms; forms multiple; treatment ... See more keywords
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Multiple sclerosis"
DOI: 10.1177/13524585211000280
Abstract: BACKGROUND Disease-modifying therapies (DMTs) can reduce the risk of disability worsening in patients with relapsing forms of multiple sclerosis (RMS). High-efficacy DMTs can lead to confirmed or sustained disability improvement (CDI and SDI). OBJECTIVE AND… read more here.
Keywords: relapsing forms; forms multiple; disability; disability improvement ... See more keywords
Ofatumumab for relapsing forms of multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2022 at "Drugs of today"
DOI: 10.1358/dot.2022.58.1.3353168
Abstract: In recent years, B cells have been extensively studied as a therapeutic target in multiple sclerosis (MS). Particularly, anti-CD20 monoclonal antibodies (MAbs) such as rituximab or ocrelizumab have proven to be effective in treating various… read more here.
Keywords: relapsing forms; anti cd20; forms multiple; ofatumumab relapsing ... See more keywords
Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
Sign Up to like & getrecommendations! Published in 2020 at "Neurology International"
DOI: 10.3390/neurolint12030016
Abstract: Multiple sclerosis (MS) is a prevalent and debilitating neurologic condition characterized by widespread neurodegeneration and the formation of focal demyelinating plaques in the central nervous system. Current therapeutic options are complex and attempt to manage… read more here.
Keywords: sclerosis; forms multiple; efficacy; drug ... See more keywords